Table 5.
References | Risk factors | HR (95% CI) | P |
---|---|---|---|
Song et al. (2011) | Age | 1.017 (1.001–1.033) | 0.032 |
FVC, % pred | 0.987 (0.977–0.997) | 0.009 | |
DLco, % pred | 0.985 (0.976–0.994) | 0.001 | |
Steroid with/without | 1.552 (1.113–2.164) | 0.01 | |
cytotoxic agent occurrence of AE | 2.592 (1.888–3.560) | P < 0.001 | |
Kakugawa et al. (2016) | Cardiovascular diseases | 2.37 (1.03–5.44) | 0.042 |
GAP stage (≥ II) | 3.63 (1.47–8.93) | 0.005 | |
SP-D, ng/mL | 3.21 (1.21–8.48) | 0.019 |
The FVC% value and the DLCO% value were obtained within one month after the first diagnosis.
FVC forced vital capacity, % pred % predicted, DLco diffusing capacity of the lung for carbon monoxide, AE acute exacerbation, GAP gender-age physiology, SP-D surfactant protein-D.